Calcineurin Inhibitor-Sparing Regimens In Solid Organ Transplantation: Focus On Improving Renal Function And Nephrotoxicity
BERKELEY, CA (UroToday.com) - Clinical solid organ transplantation is a great success story, and when permanent failure of the kidney, liver, heart, or lung occurs, replacement by transplant is the preferred treatment option. Today with 1-year graft survivals approaching 90% the number of waiting recipients far outstrips organ supply, which has limited further expansion.
More: continued here
Filed under: Transplants on February 26th, 2008